13/09/2022
https://www.ensilitech.com/EnsiliTech, a Spin Up Science Ventures portfolio company, announce today they have spun-out of the University of Bath.
EnsiliTech have developed a method to make biologicals stable without refrigeration. Vaccines, antibodies and proteins are susceptible to degradation at room temperature and hence rely on an extensive network of refrigeration and cold storage transport known as the cold chain, which sees 50% of vaccines wasted each year due to failures in temperature control. EnsiliTech’s technology encases these biologicals in a protective silica matrix to prevent degradation, reducing wastage and increasing the accessibility of vaccines and antibodies across the globe to low- and middle-income countries where there is a lack sufficient cold chain infrastructure.
The technology has been developed by the founding team: Dr Asel Sartbaeva, Dr Aswin Doekhie, Dr Stephen Wells and Dr Matt Slade. Dr Sartbaeva has participated in several Spin Up Academy Programs, before deciding to pursue the spinout route, and in the last year, the team joined Spin Up Science Ventures, a venture accelerator dedicated to supporting early stage academic breakthroughs. They then went on to secure funding in the InnovateUK ICURe program and having recently been awarded a £300k follow-on Innovate UK grant, EnsiliTech are currently fundraising match investment. https://www.spin-up.science/blog/ensilitech-spin-out-of-university-of-bath
